These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27458096)

  • 21. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
    Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
    J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines.
    Prasad A; Khudaynazar N; Tantravahi RV; Gillum AM; Hoffman BS
    Oncotarget; 2016 Nov; 7(48):79388-79400. PubMed ID: 27764820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway.
    Hu J; Li G; Liu Z; Ma H; Yuan W; Lu Z; Zhang D; Ling H; Zhang F; Liu Y; Liu C; Qiu Y
    Mol Carcinog; 2023 May; 62(5):628-640. PubMed ID: 36727616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
    Chang WC; Wu SL; Huang WC; Hsu JY; Chan SH; Wang JM; Tsai JP; Chen BK
    Oncotarget; 2015 Apr; 6(10):7741-57. PubMed ID: 25797258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway.
    Hou Y; Zhou M; Li Y; Tian T; Sun X; Chen M; Xu W; Lu M
    Mol Carcinog; 2022 Aug; 61(8):797-811. PubMed ID: 35687049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
    Zhang X; Wu J; Luo S; Lechler T; Zhang JY
    Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.
    Oh SH; Kang JH; Kyu Woo J; Lee OH; Kim ES; Lee HY
    Int J Cancer; 2012 Aug; 131(3):537-47. PubMed ID: 22113431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway.
    Liu P; Kong X; Yi S; Chen Y; Luo W
    World J Surg Oncol; 2024 Jan; 22(1):34. PubMed ID: 38273364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profilin 2 Promotes Proliferation and Metastasis of Head and Neck Cancer Cells by Regulating PI3K/AKT/β-Catenin Signaling Pathway.
    Zhou K; Chen J; Wu J; Xu Y; Wu Q; Yue J; Song Y; Li S; Zhou P; Tu W; Yang G; Jiang S
    Oncol Res; 2019 Sep; 27(9):1079-1088. PubMed ID: 31122311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation.
    Manavathi B; Lo D; Bugide S; Dey O; Imren S; Weiss MJ; Humphries RK
    J Biol Chem; 2012 Feb; 287(8):5600-14. PubMed ID: 22187427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways.
    Sur S; Nakanishi H; Steele R; Ray RB
    BMC Cancer; 2019 Apr; 19(1):354. PubMed ID: 30987615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Sambandam V; Fernandez AM; Zhao H; Mazumdar T; Shen L; Wang Q; Ahmed KM; Ghosh S; Frederick MJ; Wang J; Johnson FM
    Cancer Res; 2022 Dec; 82(23):4444-4456. PubMed ID: 36169922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.